Feature | Molecular Imaging | June 29, 2015

SNMMI Presents Nuclear Imaging Diagnosis and Treatment Advances at 2015 Annual Meeting

New events this year included pre-meeting symposium on internal radiation dose best practices

SNMMI, 2015 annual meeting, nuclear medicine, molecular imaging, Baltimore

June 29, 2015 - More than 5,000 physicians, technologists, scientists and exhibitors gathered at the Society of Nuclear Medicine and Molecular Imaging's (SNMMI) 2015 annual meeting, June 6-10 in Baltimore. In addition to the more than 100 continuing education sessions, more than 2,000 scientific papers and posters were presented at the meeting and more than 165 companies were represented on the exhibit hall floor.

New this year was a pre-meeting symposium on best practices for medical internal radiation doses. It provided an update on the current status of radiopharmaceutical therapy (RPT), with a particular emphasis on the key role played by dosimetry. RPT, or therapeutic nuclear medicine, is an underutilized modality with great potential; dosimetry can provide guidelines for safer and more effective treatment planning, in addition to providing insight into tumor dose-response relations.

The annual meeting officially opened with the SNMMI plenary session June 7, as Franí§ois Bernard, M.D., presented the Henry Wagner Jr, M.D., Lecture, "Accelerating Nuclear Medicine with Cylotron-Produced Tc-99m." With current reliance on aging international reactors for a supply of this most commonly used medical radionuclide, the development of a domestic, reliable source is critical. Later that day, Rosemary Gibson from the Hastings Center presented "The Human Face of Quality and Patient Safety" at the SNMMI Technologist Section plenary.

Quality and safety went hand-in-hand with research advances as a constant theme throughout the meeting. At the press conference, the new president of SNMMI, Hossein Jadvar, M.D., Ph.D., MPH, MBA, FACNM, emphasized the society's continued focus on quality of care and patient safety. The society's Department of Evidence and Quality is developing evidence-based, appropriate use criteria for procedures, beginning with those most frequently ordered. Jadvar stated, "The development of appropriate use criteria will help establish standards - greatly benefiting patients."

He also announced the creation of a Therapy Center of Excellence, which will bring together a multidisciplinary group of experts in targeted radionuclide therapy to assist in the development of emerging agents, provide advocacy for regulatory approval and advance the use of approved agents. "We have entered the frontier of personalized and precision medicine, and we are the pioneers," Jadvar said. "I cannot imagine a more exciting time to be in the nuclear medicine field."

SNMMI honored several leaders in the field at its two plenary sessions. Michael E. Phelps, Ph.D., the Norton Simon professor and chair of the University of California, Los Angeles (UCLA), Department of Molecular and Medical Pharmacology, was named as this year's recipient of the Georg Charles de Hevesy Nuclear Pioneer Award for his contributions to the nuclear medicine profession. Best known as the inventor of positron emission tomography (PET), he has made major contributions to the field for more than four decades.

David W. Townsend, Ph.D., professor in the Department of Diagnostic Imaging at the National University Hospital of Singapore and director of the A*STAR-NUS Clinical Imaging Research Center in Singapore, received the prestigious Paul C. Aebersold Award for achievement in basic nuclear medicine. He introduced 3-D PET imaging and developed a practical and effective PET/CT (computed tomography) camera that enables nuclear medicine and molecular imaging professionals to produce high-quality images for more than 3 million patients each year.

The special plenary session welcomed the new leadership team for SNMMI. In addition to President Jadvar, it includes Sally W. Schwarz, MS, RPh, BCNP, in the position of president-elect, and Bennett S. Greenspan, M.D., MS, FACNM, FACR, as vice president-elect. The leadership for SNMMI's Technologist Section also changed hands during the meeting, with Aaron Scott, MIS, CNMT, NCAA, SNMMI-TS, taking the helm as president and Sara G. Johnson, MBA, CNMT, NCT, FSNMMI-TS, serving as president-elect.

Also announced was the SNMMI 2015 Image of the Year. The honor was given to Matthias Eder, Ph.D., and his colleagues at the German Cancer Research Center in Heidelberg, Germany, and at the Department of Nuclear Medicine at University Hospital Heidelberg for their image (scientific paper #63) - illustrating the potential effectiveness of a novel theranostic, PSMA-617, for treating patients with hormone-refractory prostate cancer, which is difficult to control and currently has a poor prognosis. PSMA-617 has the combined capability of diagnosis and therapy.

For more information: www.snmmi.org

Related Content

NIH Study of Brain Energy Patterns Provides New Insights into Alcohol Effects

NIH scientists present a new method for combining measures of brain activity (left) and glucose consumption (right) to study regional specialization and to better understand the effects of alcohol on the human brain. Image courtesy of Ehsan Shokri-Kojori, Ph.D., of NIAAA.

News | Neuro Imaging | March 22, 2019
March 22, 2019 — Assessing the patterns of energy use and neuronal activity simultaneously in the human brain improve
Improving Molecular Imaging Using a Deep Learning Approach
News | Nuclear Imaging | March 21, 2019
Generating comprehensive molecular images of organs and tumors in living organisms can be performed at ultra-fast speed...
PET Scans Show Biomarkers Could Spare Some Breast Cancer Patients from Chemotherapy
News | PET Imaging | March 18, 2019
A new study positron emission tomography (PET) scans has identified a biomarker that may accurately predict which...
Researchers Create New Method for Developing Cancer Imaging Isotopes

Prototype fluidic system for zirconium-89 purification. Image taken through a hot cell window at the Department of Radiology, University of Washington. Image courtesy of Matthew O’Hara, Pacific Northwest National Laboratory

News | Radiopharmaceuticals and Tracers | March 14, 2019
A team of researchers at the University of Washington announced they developed a new automated system for producing...
Siemens Healthineers Announces First U.S. Install of Biograph Vision PET/CT
News | PET-CT | March 06, 2019
Siemens Healthineers’ new Biograph Vision positron emission tomography/computed tomography (PET/CT) system has been...
ImaginAb Enrolls First Patient in Phase II PET Agent Clinical Trial
News | Radiopharmaceuticals and Tracers | January 30, 2019
ImaginAb Inc. announced the enrollment of the first patient in the Phase II clinical trial of the company’s CD8+ T Cell...
FDA Clears United Imaging Healthcare uExplorer Total-Body Scanner
Technology | PET-CT | January 23, 2019
January 23, 2019 — United Imaging Healthcare (United Imaging) announced U.S.
MIM Software Inc. Receives FDA 510(k) Clearance for Molecular Radiotherapy Dosimetry
Technology | Nuclear Imaging | January 16, 2019
MIM Software Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for molecular radiotherapy...
Videos | SPECT-CT | December 12, 2018
This is a walk around of the new Spectrum Dynamics Veriton SPECT-CT nuclear imaging system introduced at the 2018 ...